37. The Tragedy of Plazomicin
ID:IOTS - Infectious Disease Insight Of Two Specialists
00:00
The Downfall of Plazomicin
This chapter explores the challenges faced by Plazomicin, a promising antibiotic, in gaining approval in Europe due to stringent regulations and narrow usage indications. It discusses financial and logistical barriers that inhibit the development of innovative antibiotics compared to more lucrative medications. The conversation highlights the crucial need for a balanced approach in incentivizing pharmaceutical companies while ensuring the availability of effective antimicrobial therapies.
Transcript
Play full episode
